Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Cancer Manag Res. 2013 Sep 13;5:315-25. doi: 10.2147/CMAR.S33056. eCollection 2013.
Whole-gland low-dose rate (LDR) brachytherapy has been a well-established modality of treating low-risk prostate cancer. Treatment in a focal manner has the advantages of reduced toxicity to surrounding organs. Focal treatment using LDR brachytherapy has been relatively unexplored, but it may offer advantages over other modalities that have established experiences with a focal approach. This is particularly true as prostate cancer is being detected at an earlier and more localized stage with the advent of better detection methods and newer imaging modalities.
全腺体低剂量率（LDR）近距离放射治疗已成为治疗低危前列腺癌的一种成熟模式。局部治疗具有降低周围器官毒性的优势。使用 LDR 近距离放射治疗进行局部治疗相对较少被探索，但它可能比其他具有局部治疗经验的治疗方式具有优势。随着更好的检测方法和新的成像方式的出现，前列腺癌在更早和更局限的阶段被发现，这种情况尤其如此。
